“
“Objective: Characterize the incidence and timing of fetal heart rate (FHR) and cardiotocographic abnormalities (CTG) associated
with the misoprostol vaginal insert (MVI) during labor induction. Methods: This secondary analysis of data from the MVI Trial, a multi-site, double-masked, randomized trial of 374 women assigned to MVI 100, 150 or 200 mcg buy CH5424802 requiring cervical ripening before labor induction evaluated the incidence and clinical outcomes associated with FHR and CTG abnormalities diagnosed using 1997 NICHD definitions. Results: MVI 200 was associated with an increased rate of tachysystole versus MVI 100 (p < 0.001, RR 2.11, 95% CI 1.39, 3.22) but not MVI 150 (p = 0.29, RR 1.31, 95% CI 0.82, 2.11). Tachysystole occurred with the drug in situ in 17 (14.4%) and 50 (38.2%) of MVI 100 and 200 subjects, respectively (p < 0.001). Category II or III FHR patterns after tachysystole occurred in 9 (7.6%) and 26 (19.8%) women in MVI 100 and 200 groups, (p = 0.006). Abnormal FHR patterns were the indication for cesarean in 18 (13.7%) MVI 200 women versus 11 (9.3%) MVI 100 women
(p = 0.33). Neonatal outcomes were similar between groups. Conclusions: While FHR and CTG abnormalities were encountered frequently during all inductions, few were clinically significant.”
“Objective: To explore factors affecting tobacco users’ perceived appropriateness of a brief and proactive tobacco cessation counseling program, ask, advise, and refer (AAR), at community pharmacies.
Design: Inductive Small molecule library ic50 thematic analysis.
Setting: Southern Wisconsin during fall 2008.
Patients: 24 tobacco users who had recently received brief and proactive tobacco cessation counseling at a community pharmacy.
Intervention:
Semistructured telephone interviews conducted by primary author.
Main outcome measures: Perceptions of a brief and proactive tobacco cessation counseling program conducted at community pharmacies.
Results: In conducting the thematic analysis, eight distinct themes were identified. Display of information and resources at pharmacies for use by tobacco users as needed was identified as the most predominant theme and was found to be most helpful by many respondents. Other themes identified in decreasing SBI-0206965 cell line order of prevalence were: tobacco users’ perceptions of the role of pharmacists in health care, tobacco users’ belief that smoking could interact with a current medication or health condition, tobacco users’ sensitivity toward their tobacco use behavior or being told what to do, nonconfrontational and friendly approach of pharmacists, tobacco users’ readiness to quit at the time of AAR counseling, tobacco user initiation of tobacco use discussion, and tobacco users’ belief that tobacco use is bad.
Conclusion: Overall, this qualitative investigation suggests that several factors might influence tobacco users’ perceived appropriateness of AAR counseling at community pharmacies.